Work

A phase II study of erlotinib followed by chemotherapy on progression in an unselected population of advanced non-small cell lung cancer (NSCLC) patients.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.7568

Authors: Leora Horn, Chung-I Li, William Pao, Vicki Leigh Keedy, David H. Johnson, David P Carbone

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, The University of Texas Southwestern Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599704650

Cites:

Cited by:

Related to: 10